All eyes are on Croda International. The speciality chemicals business, long regarded as one of Britain’s best companies and a perfect buy-and-hold-on-to-for-life investment, has a bright future yet was one of the worst performers in the FTSE 100 last year and has more than halved in value since the end of 2021. You might assume that now is a good time to buy. Sadly, it isn’t that simple. Sharp sell-offs do not necessarily lead to attractive valuations.
Croda’s unique concoctions improve the quality and performance of everything from skin cream, suntan lotion, shampoo and television screens to crops, drugs and vaccines. They also, unlike some of the competition, happen to be created mainly from natural materials.
Companies worldwide are reliant on Croda’s special ingredients. Without
